BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9697277)

  • 1. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.
    Howe DT; Gornall R; Wellesley D; Boyle T; Barber J
    BMJ; 2000 Mar; 320(7235):606-10. PubMed ID: 10698877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.
    Gekas J; Gagné G; Bujold E; Douillard D; Forest JC; Reinharz D; Rousseau F
    BMJ; 2009 Feb; 338():b138. PubMed ID: 19218323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the ratio of second trimester fetal biometric measurements to fetal nasal bone length in fetuses with normal karyotype and trisomy 21.
    Dal Y; Akkuş F; Karagün Ş; Coşkun A
    J Clin Ultrasound; 2024 May; 52(4):368-376. PubMed ID: 38318757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of fetal left-right asymmetry disorders associated with maternal SARS-CoV-2 infection during the first trimester.
    Li Y; Wang Y; Wu H; Li Q; Li S; Qiu C; Qiu S; Niu Q; Zhang X; Xiong Y; Tao G
    Sci Rep; 2024 May; 14(1):11422. PubMed ID: 38763951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The likelihood of detecting abnormal karyotypes in fetuses with a single major anomaly or "soft" marker on ultrasonographic scanning.
    Petrovic B; Milicevic S; Sljivancanin D; Zdelar Stojanovic L; Stamenkovic J; Grk M; Dusanovic Pjevic M
    Clin Dysmorphol; 2024 Jul; 33(3):137-144. PubMed ID: 38410977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in maternal age distribution and the live birth prevalence of Down's syndrome in England and Wales: 1938-2010.
    Wu J; Morris JK
    Eur J Hum Genet; 2013 Sep; 21(9):943-7. PubMed ID: 23361224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of objectively measured physical activity levels in individuals with intellectual disabilities with and without Down's syndrome.
    Phillips AC; Holland AJ
    PLoS One; 2011; 6(12):e28618. PubMed ID: 22205957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal Echogenic Bowel: What Is Real Echogenicity? A Quantitative Method Based on Histogram Analysis of the Grayscale.
    Spinnato S; De Biase A; Bilardo CM; Elvan-Taşpınar A
    Fetal Diagn Ther; 2024; 51(2):145-153. PubMed ID: 37995667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Invasive Screening Tools for Down's Syndrome: A Review.
    Sillence KA; Madgett TE; Roberts LA; Overton TG; Avent ND
    Diagnostics (Basel); 2013 May; 3(2):291-314. PubMed ID: 26835682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current use of medical eponyms--a need for global uniformity in scientific publications.
    Jana N; Barik S; Arora N
    BMC Med Res Methodol; 2009 Mar; 9():18. PubMed ID: 19272131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics of placental chorioangioma: A clinicopathological study of 30 cases.
    Zheng Y; Liu X; Mao Y; Lin M
    Indian J Pathol Microbiol; 2024 Mar; ():. PubMed ID: 38563706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed presentation of congenital rectal stenosis associated with Down's syndrome and hypothyroidism: Case report.
    Chowdhury TK; Hoque MM; Kabir M; Banu T
    Clin Case Rep; 2021 Nov; 9(11):e05083. PubMed ID: 34815875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catatonia in Down's syndrome: An under-recognized syndrome during regression.
    Jakubowicz B; Baptista A; Ravel A; Cieuta C; Mircher C; Cohen D; Consoli A; Raffin M
    Schizophr Res; 2023 Nov; 261():107-109. PubMed ID: 37716203
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of biochemical and ultrasound markers in the detection of down syndrome.
    Peterson CC
    J Perinat Educ; 2006; 15(1):19-25. PubMed ID: 17322941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecule of the month: miRNA and Down's syndrome.
    Shapshak P
    Bioinformation; 2013; 9(15):752-4. PubMed ID: 24023415
    [No Abstract]   [Full Text] [Related]  

  • 18. How can you examine intersection syndrome via ultrasound? A technical description.
    Giray E; Keles Ercisli A; İlleez ÖG; Aktaş İ; Yağcı İ
    Arch Rheumatol; 2023 Jun; 38(2):324-325. PubMed ID: 37680506
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.